We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00409214
Recruitment Status : Completed
First Posted : December 8, 2006
Last Update Posted : November 16, 2012
Information provided by (Responsible Party):
Light Sciences Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2008
  Study Completion Date : No date given